{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:17:42Z","timestamp":1778696262937,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.rbmo.2020.07.024","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T13:21:16Z","timestamp":1596115276000},"page":"854-858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["GnRH agonist triggering followed by 1500 IU of HCG 48 h after oocyte retrieval for luteal phase support"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2899-5295","authenticated-orcid":false,"given":"Shahar","family":"Kol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linoy","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2020.07.024_bib0001","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/humrep\/dev184","article-title":"Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial","volume":"30","author":"Andersen","year":"2015","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0002","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1093\/humrep\/deu194","article-title":"A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization","volume":"29","author":"Baker","year":"2014","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0003","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.fertnstert.2016.04.004","article-title":"Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders","volume":"106","author":"Bar-Hava","year":"2016","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0004","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0006","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/humrep\/dev155","article-title":"Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients","volume":"30","author":"Goldrat","year":"2015","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1016\/j.rbmo.2020.07.024_bib0007","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1757-2215-7-35","article-title":"HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept","volume":"3","author":"Haas","year":"2014","journal-title":"Journal of Ovarian Research"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0008","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0009","article-title":"Survey on vitrification","year":"2013","journal-title":"GnRH trigger and differed embryo transfer"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000491088","article-title":"A Rationale for Timing of Luteal Support Post Gonadotropin-Releasing Hormone Agonist Trigger","volume":"84","author":"Kol","year":"2019","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0012","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.fertnstert.2010.09.023","article-title":"A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study","volume":"95","author":"Papanikolaou","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0013","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10815-014-0248-6","article-title":"Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience","volume":"31","author":"Reddy","year":"2014","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0014","first-page":"1470","article-title":"Enhanced ovarian steroid secretion before implantation in early human pregnancy","volume":"76","author":"Stewart","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/09513590.2017.1318275","article-title":"GnRH-agonist triggering for final oocyte maturation in GnRH-antagonist IVF cycles induces decreased LH pulse rate and amplitude in early luteal phase: a possible luteolysis mechanism","volume":"33","author":"Tannus","year":"2017","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0016","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/humrep\/dey226","article-title":"The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF\/ICSI cycles","volume":"33","author":"Thomsen","year":"2018","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/09513590.2017.1379496","article-title":"Day two post retrieval 1500 IUI hCG bolus, progesterone-free luteal support post GnRH agonist trigger - a proof of concept study","volume":"34","author":"Vanetik","year":"2018","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/humrep\/dez235","article-title":"The early luteal hormonal profile in IVF patients triggered with hCG","volume":"35","author":"Vuong","year":"2020","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0019","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.rbmo.2019.07.031","article-title":"Repeated GnRH agonist doses for luteal support: a proof of concept","volume":"39","author":"Wiser","year":"2019","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0035-1545363","article-title":"Luteal phase support in in vitro fertilization","volume":"33","author":"Yanushpolsky","year":"2015","journal-title":"Seminars in Reproductive Medicine"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.rbmo.2014.01.012","article-title":"2014 improving the luteal phase after ovarian stimulation: reviewing new options","volume":"28","author":"Yding Andersen","year":"2014","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1016\/j.rbmo.2020.07.024_bib0022","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1471-0528.1985.tb01112.x","article-title":"Hormonal profiles in the follicular phase, luteal phase and first trimester of pregnancies arising from in vitro fertilization","volume":"92","author":"Yovich","year":"1985","journal-title":"British Journal of Obstetrics and Gynaecology"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320303953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320303953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:19:06Z","timestamp":1761466746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648320303953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1472648320303953"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.07.024","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GnRH agonist triggering followed by 1500 IU of HCG 48 h after oocyte retrieval for luteal phase support","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}